Clinical Trials Directory

Trials / Terminated

TerminatedNCT02907814

Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography

Objective, Prospective Measurement of Anterior Chamber Cell Grading Using Anterior Chamber Ocular Coherence Tomography

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
6 (actual)
Sponsor
Rutgers, The State University of New Jersey · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Optical Coherence Tomography (OCT) is routinely used in ophthalmic clinical practice. It uses infrared light to image patient's eyes. Some patients, such as those with an inflammatory disease called uveitis or those who have just undergone cataract surgery, have intraocular inflammation. This intraocular inflammation commonly manifests as cells that can be seen on routine microscopic clinical examination. However, the only currently available method to quantify this intraocular inflammation is by manually counting on the microscopic clinical examination. The investigators plan to use the OCT machine to image patient's eyes. The investigators will then use the images obtained from the OCT to objectively quantify the degree of intraocular inflammation.

Conditions

Interventions

TypeNameDescription
DEVICEOptical Coherence Tomography (OCT)The OCT scan is a brief, non-contact scan of the back of the eye using infrared light. Subjects will see a light and be asked to look forwards while the scan is completed.
OTHEREye ExamThis is a brief, non-contact ocular exam.

Timeline

Start date
2016-09-01
Primary completion
2018-04-01
Completion
2018-04-01
First posted
2016-09-20
Last updated
2019-05-06
Results posted
2019-05-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02907814. Inclusion in this directory is not an endorsement.